Posted On: 12/28/2016 3:17:12 PM
Post# of 72446
Re: Crownbiotech #29806
With 25 sites recruiting, most of the trial expenses, if not all, are paid for. CTIX had ~$5.6M in cash according to the most recent 10-Q. So they don't need much to pay for the whole thing.
"As of September 30, 2016, we had approximately $5.6 million in cash and cash equivalents and $20 million remaining available for stock sales under the terms of the purchase agreement with Aspire Capital, compared to $6.3 million of cash and cash equivalents as of June 30, 2016."
https://www.sec.gov/Archives/edgar/data/13552...ix_10q.htm
"As of September 30, 2016, we had approximately $5.6 million in cash and cash equivalents and $20 million remaining available for stock sales under the terms of the purchase agreement with Aspire Capital, compared to $6.3 million of cash and cash equivalents as of June 30, 2016."
https://www.sec.gov/Archives/edgar/data/13552...ix_10q.htm
Quote:
All I know is what Leo said of the P2B costs (6/7 mil). We don't know the current cash position and how much more will be needed?
(1)
(0)
